David Brayden is Full Professor of Advanced Drug Delivery at the School of Veterinary Medicine, University College Dublin (UCD). He is also a Senior Fellow of the UCD Conway Institute of Biotechnology. David is a pharmacologist and spent 10 years as a senior scientist and programme manager at Elan Biotechnology Research working on oral delivery of macromolecules. He is the author or co-author of more than 250 research publications and patents in the areas of oral peptide delivery and nanomedicine. He is currently a co-lead Principal Investigator in the Science Foundation Ireland Centre for Medical Devices (CURAM II). He was Deputy Coordinator of the FP7 consortium, TRANS-INT, which worked on oral peptide nanoparticles from 2012-2017. David was elected as a Fellow of both the Controlled Release Society (2012) and the American Association of Pharmaceutical Scientists (2017). He was appointed to the role of Chief Editor of Frontiers in Drug Delivery in 2021.